Hong Kong Med J 2024;30(Suppl 1):S34-8
Faecal microbiota transplantation for patients with irritable bowel syndrome: abridged secondary publication
YK Yau1,2,3, Q Su1,2,3, Z Xu1,2,3, W Tang1,2,3, JYL Ching1,2, CP Cheung1,2,3, M Fung1,2,3, M Ip4, PKS Chan4, FKL Chan1,2,3, SC Ng1,2,3
1 Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China
2 Microbiota I-Center (MagIC), Hong Kong SAR, China
3 Li Ka Shing Institute of Health Sciences, State Key Laboratory of Digestive Disease, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong SAR, China
4Department of Microbiology, The Chinese University of Hong Kong, Hong Kong SAR, China
YK Yau and Q Su contributed equally
 
 
  1. Faecal microbiota transplantation, delivered twice at an interval of 4 weeks, was not associated with overall improvement in irritable bowel syndrome symptoms.
  2. Faecal microbiota transplantation relieved the most annoying symptom—abdominal bloating—likely by reducing hydrogen sulphide–producing bacteria in the gut.
  3. Additional studies are needed to determine the optimal regimen.